nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP2D6—Fingolimod—multiple sclerosis	0.166	0.217	CbGbCtD
Halofantrine—CYP3A4—Fingolimod—multiple sclerosis	0.105	0.138	CbGbCtD
Halofantrine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0679	0.0889	CbGbCtD
Halofantrine—CYP3A5—Dexamethasone—multiple sclerosis	0.0659	0.0862	CbGbCtD
Halofantrine—CYP2C8—Dexamethasone—multiple sclerosis	0.0634	0.0829	CbGbCtD
Halofantrine—CYP3A4—Triamcinolone—multiple sclerosis	0.0515	0.0673	CbGbCtD
Halofantrine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0496	0.0648	CbGbCtD
Halofantrine—CYP3A4—Betamethasone—multiple sclerosis	0.0442	0.0578	CbGbCtD
Halofantrine—CYP3A4—Prednisolone—multiple sclerosis	0.0436	0.057	CbGbCtD
Halofantrine—CYP3A4—Prednisone—multiple sclerosis	0.0412	0.0538	CbGbCtD
Halofantrine—CYP2D6—Dexamethasone—multiple sclerosis	0.0404	0.0529	CbGbCtD
Halofantrine—CYP3A4—Dexamethasone—multiple sclerosis	0.0257	0.0336	CbGbCtD
Halofantrine—Paraesthesia—Cladribine—multiple sclerosis	0.00116	0.00491	CcSEcCtD
Halofantrine—Depressed level of consciousness—Methotrexate—multiple sclerosis	0.00114	0.00485	CcSEcCtD
Halofantrine—Abdominal distension—Triamcinolone—multiple sclerosis	0.00113	0.00481	CcSEcCtD
Halofantrine—Abdominal distension—Methylprednisolone—multiple sclerosis	0.00113	0.00479	CcSEcCtD
Halofantrine—Decreased appetite—Cladribine—multiple sclerosis	0.00112	0.00476	CcSEcCtD
Halofantrine—Fatigue—Cladribine—multiple sclerosis	0.00111	0.00472	CcSEcCtD
Halofantrine—Constipation—Cladribine—multiple sclerosis	0.0011	0.00468	CcSEcCtD
Halofantrine—Myalgia—Azathioprine—multiple sclerosis	0.00109	0.00464	CcSEcCtD
Halofantrine—Arthralgia—Azathioprine—multiple sclerosis	0.00109	0.00464	CcSEcCtD
Halofantrine—Discomfort—Azathioprine—multiple sclerosis	0.00108	0.00459	CcSEcCtD
Halofantrine—Chills—Mitoxantrone—multiple sclerosis	0.00107	0.00454	CcSEcCtD
Halofantrine—Arrhythmia—Mitoxantrone—multiple sclerosis	0.00107	0.00452	CcSEcCtD
Halofantrine—Feeling abnormal—Cladribine—multiple sclerosis	0.00106	0.00451	CcSEcCtD
Halofantrine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00105	0.00448	CcSEcCtD
Halofantrine—Pulmonary oedema—Methotrexate—multiple sclerosis	0.00105	0.00447	CcSEcCtD
Halofantrine—Urticaria—Cladribine—multiple sclerosis	0.00102	0.00435	CcSEcCtD
Halofantrine—Abdominal pain—Cladribine—multiple sclerosis	0.00102	0.00433	CcSEcCtD
Halofantrine—Back pain—Mitoxantrone—multiple sclerosis	0.001	0.00426	CcSEcCtD
Halofantrine—Face oedema—Prednisone—multiple sclerosis	0.000992	0.00421	CcSEcCtD
Halofantrine—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000963	0.00409	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000955	0.00405	CcSEcCtD
Halofantrine—Visual impairment—Prednisolone—multiple sclerosis	0.000943	0.004	CcSEcCtD
Halofantrine—Malaise—Mitoxantrone—multiple sclerosis	0.000936	0.00398	CcSEcCtD
Halofantrine—Asthenia—Cladribine—multiple sclerosis	0.000925	0.00393	CcSEcCtD
Halofantrine—Pruritus—Cladribine—multiple sclerosis	0.000912	0.00387	CcSEcCtD
Halofantrine—Cough—Mitoxantrone—multiple sclerosis	0.000906	0.00385	CcSEcCtD
Halofantrine—Convulsion—Mitoxantrone—multiple sclerosis	0.000899	0.00382	CcSEcCtD
Halofantrine—Abdominal distension—Prednisone—multiple sclerosis	0.000894	0.0038	CcSEcCtD
Halofantrine—Arthralgia—Mitoxantrone—multiple sclerosis	0.000884	0.00375	CcSEcCtD
Halofantrine—Myalgia—Mitoxantrone—multiple sclerosis	0.000884	0.00375	CcSEcCtD
Halofantrine—Chest pain—Mitoxantrone—multiple sclerosis	0.000884	0.00375	CcSEcCtD
Halofantrine—Diarrhoea—Cladribine—multiple sclerosis	0.000882	0.00375	CcSEcCtD
Halofantrine—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.000876	0.00372	CcSEcCtD
Halofantrine—Arrhythmia—Prednisolone—multiple sclerosis	0.000874	0.00371	CcSEcCtD
Halofantrine—Discomfort—Mitoxantrone—multiple sclerosis	0.000873	0.00371	CcSEcCtD
Halofantrine—Visual impairment—Methylprednisolone—multiple sclerosis	0.000865	0.00367	CcSEcCtD
Halofantrine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000863	0.00367	CcSEcCtD
Halofantrine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000857	0.00364	CcSEcCtD
Halofantrine—Confusional state—Mitoxantrone—multiple sclerosis	0.000854	0.00363	CcSEcCtD
Halofantrine—Dizziness—Cladribine—multiple sclerosis	0.000852	0.00362	CcSEcCtD
Halofantrine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000847	0.0036	CcSEcCtD
Halofantrine—Abdominal pain—Azathioprine—multiple sclerosis	0.000828	0.00352	CcSEcCtD
Halofantrine—Vomiting—Cladribine—multiple sclerosis	0.000819	0.00348	CcSEcCtD
Halofantrine—Rash—Cladribine—multiple sclerosis	0.000813	0.00345	CcSEcCtD
Halofantrine—Dermatitis—Cladribine—multiple sclerosis	0.000812	0.00345	CcSEcCtD
Halofantrine—Anorexia—Mitoxantrone—multiple sclerosis	0.000807	0.00343	CcSEcCtD
Halofantrine—Headache—Cladribine—multiple sclerosis	0.000807	0.00343	CcSEcCtD
Halofantrine—Arrhythmia—Triamcinolone—multiple sclerosis	0.000804	0.00341	CcSEcCtD
Halofantrine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000802	0.00341	CcSEcCtD
Halofantrine—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00079	0.00336	CcSEcCtD
Halofantrine—Visual impairment—Betamethasone—multiple sclerosis	0.000787	0.00334	CcSEcCtD
Halofantrine—Visual impairment—Dexamethasone—multiple sclerosis	0.000787	0.00334	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000772	0.00328	CcSEcCtD
Halofantrine—Malaise—Prednisolone—multiple sclerosis	0.000768	0.00326	CcSEcCtD
Halofantrine—Nausea—Cladribine—multiple sclerosis	0.000765	0.00325	CcSEcCtD
Halofantrine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000761	0.00323	CcSEcCtD
Halofantrine—Back pain—Triamcinolone—multiple sclerosis	0.000757	0.00322	CcSEcCtD
Halofantrine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000746	0.00317	CcSEcCtD
Halofantrine—Convulsion—Prednisolone—multiple sclerosis	0.000738	0.00313	CcSEcCtD
Halofantrine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000736	0.00313	CcSEcCtD
Halofantrine—Fatigue—Mitoxantrone—multiple sclerosis	0.00073	0.0031	CcSEcCtD
Halofantrine—Arrhythmia—Betamethasone—multiple sclerosis	0.000729	0.0031	CcSEcCtD
Halofantrine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000729	0.0031	CcSEcCtD
Halofantrine—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000727	0.00309	CcSEcCtD
Halofantrine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000725	0.00308	CcSEcCtD
Halofantrine—Constipation—Mitoxantrone—multiple sclerosis	0.000724	0.00308	CcSEcCtD
Halofantrine—Diarrhoea—Azathioprine—multiple sclerosis	0.000717	0.00305	CcSEcCtD
Halofantrine—Discomfort—Prednisolone—multiple sclerosis	0.000716	0.00304	CcSEcCtD
Halofantrine—Malaise—Triamcinolone—multiple sclerosis	0.000706	0.003	CcSEcCtD
Halofantrine—Malaise—Methylprednisolone—multiple sclerosis	0.000705	0.00299	CcSEcCtD
Halofantrine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000698	0.00296	CcSEcCtD
Halofantrine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000695	0.00295	CcSEcCtD
Halofantrine—Dizziness—Azathioprine—multiple sclerosis	0.000693	0.00294	CcSEcCtD
Halofantrine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000693	0.00294	CcSEcCtD
Halofantrine—Cough—Triamcinolone—multiple sclerosis	0.000683	0.0029	CcSEcCtD
Halofantrine—Convulsion—Triamcinolone—multiple sclerosis	0.000678	0.00288	CcSEcCtD
Halofantrine—Convulsion—Methylprednisolone—multiple sclerosis	0.000677	0.00288	CcSEcCtD
Halofantrine—Urticaria—Mitoxantrone—multiple sclerosis	0.000673	0.00286	CcSEcCtD
Halofantrine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00067	0.00284	CcSEcCtD
Halofantrine—Myalgia—Triamcinolone—multiple sclerosis	0.000667	0.00283	CcSEcCtD
Halofantrine—Vomiting—Azathioprine—multiple sclerosis	0.000666	0.00283	CcSEcCtD
Halofantrine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000665	0.00283	CcSEcCtD
Halofantrine—Myalgia—Methylprednisolone—multiple sclerosis	0.000665	0.00283	CcSEcCtD
Halofantrine—Rash—Azathioprine—multiple sclerosis	0.000661	0.00281	CcSEcCtD
Halofantrine—Dermatitis—Azathioprine—multiple sclerosis	0.00066	0.0028	CcSEcCtD
Halofantrine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000659	0.0028	CcSEcCtD
Halofantrine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000659	0.0028	CcSEcCtD
Halofantrine—Discomfort—Triamcinolone—multiple sclerosis	0.000659	0.0028	CcSEcCtD
Halofantrine—Discomfort—Methylprednisolone—multiple sclerosis	0.000657	0.00279	CcSEcCtD
Halofantrine—Headache—Azathioprine—multiple sclerosis	0.000656	0.00279	CcSEcCtD
Halofantrine—Stomatitis—Methotrexate—multiple sclerosis	0.000645	0.00274	CcSEcCtD
Halofantrine—Confusional state—Methylprednisolone—multiple sclerosis	0.000643	0.00273	CcSEcCtD
Halofantrine—Malaise—Dexamethasone—multiple sclerosis	0.000641	0.00272	CcSEcCtD
Halofantrine—Malaise—Betamethasone—multiple sclerosis	0.000641	0.00272	CcSEcCtD
Halofantrine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000639	0.00271	CcSEcCtD
Halofantrine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000638	0.00271	CcSEcCtD
Halofantrine—Arrhythmia—Prednisone—multiple sclerosis	0.000635	0.0027	CcSEcCtD
Halofantrine—Paraesthesia—Prednisolone—multiple sclerosis	0.000624	0.00265	CcSEcCtD
Halofantrine—Nausea—Azathioprine—multiple sclerosis	0.000622	0.00264	CcSEcCtD
Halofantrine—Convulsion—Betamethasone—multiple sclerosis	0.000616	0.00261	CcSEcCtD
Halofantrine—Convulsion—Dexamethasone—multiple sclerosis	0.000616	0.00261	CcSEcCtD
Halofantrine—Asthenia—Mitoxantrone—multiple sclerosis	0.000608	0.00258	CcSEcCtD
Halofantrine—Myalgia—Dexamethasone—multiple sclerosis	0.000605	0.00257	CcSEcCtD
Halofantrine—Myalgia—Betamethasone—multiple sclerosis	0.000605	0.00257	CcSEcCtD
Halofantrine—Discomfort—Betamethasone—multiple sclerosis	0.000598	0.00254	CcSEcCtD
Halofantrine—Discomfort—Dexamethasone—multiple sclerosis	0.000598	0.00254	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000582	0.00247	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000581	0.00247	CcSEcCtD
Halofantrine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00058	0.00246	CcSEcCtD
Halofantrine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00058	0.00246	CcSEcCtD
Halofantrine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00058	0.00246	CcSEcCtD
Halofantrine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000574	0.00244	CcSEcCtD
Halofantrine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000574	0.00244	CcSEcCtD
Halofantrine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000573	0.00243	CcSEcCtD
Halofantrine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000573	0.00243	CcSEcCtD
Halofantrine—Visual impairment—Methotrexate—multiple sclerosis	0.000572	0.00243	CcSEcCtD
Halofantrine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000563	0.00239	CcSEcCtD
Halofantrine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000561	0.00238	CcSEcCtD
Halofantrine—Malaise—Prednisone—multiple sclerosis	0.000558	0.00237	CcSEcCtD
Halofantrine—Tinnitus—Methotrexate—multiple sclerosis	0.000554	0.00235	CcSEcCtD
Halofantrine—Anorexia—Dexamethasone—multiple sclerosis	0.000553	0.00235	CcSEcCtD
Halofantrine—Anorexia—Betamethasone—multiple sclerosis	0.000553	0.00235	CcSEcCtD
Halofantrine—Urticaria—Prednisolone—multiple sclerosis	0.000552	0.00234	CcSEcCtD
Halofantrine—Fatigue—Triamcinolone—multiple sclerosis	0.000551	0.00234	CcSEcCtD
Halofantrine—Fatigue—Methylprednisolone—multiple sclerosis	0.00055	0.00234	CcSEcCtD
Halofantrine—Vomiting—Mitoxantrone—multiple sclerosis	0.000539	0.00229	CcSEcCtD
Halofantrine—Convulsion—Prednisone—multiple sclerosis	0.000536	0.00228	CcSEcCtD
Halofantrine—Rash—Mitoxantrone—multiple sclerosis	0.000534	0.00227	CcSEcCtD
Halofantrine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000534	0.00227	CcSEcCtD
Halofantrine—Chills—Methotrexate—multiple sclerosis	0.000533	0.00226	CcSEcCtD
Halofantrine—Headache—Mitoxantrone—multiple sclerosis	0.000531	0.00225	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000528	0.00224	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000528	0.00224	CcSEcCtD
Halofantrine—Myalgia—Prednisone—multiple sclerosis	0.000527	0.00224	CcSEcCtD
Halofantrine—Arthralgia—Prednisone—multiple sclerosis	0.000527	0.00224	CcSEcCtD
Halofantrine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000527	0.00224	CcSEcCtD
Halofantrine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000525	0.00223	CcSEcCtD
Halofantrine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000521	0.00221	CcSEcCtD
Halofantrine—Paraesthesia—Betamethasone—multiple sclerosis	0.000521	0.00221	CcSEcCtD
Halofantrine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000521	0.00221	CcSEcCtD
Halofantrine—Discomfort—Prednisone—multiple sclerosis	0.00052	0.00221	CcSEcCtD
Halofantrine—Dyspepsia—Dexamethasone—multiple sclerosis	0.00051	0.00217	CcSEcCtD
Halofantrine—Dyspepsia—Betamethasone—multiple sclerosis	0.00051	0.00217	CcSEcCtD
Halofantrine—Urticaria—Triamcinolone—multiple sclerosis	0.000508	0.00216	CcSEcCtD
Halofantrine—Urticaria—Methylprednisolone—multiple sclerosis	0.000507	0.00215	CcSEcCtD
Halofantrine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000505	0.00214	CcSEcCtD
Halofantrine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000504	0.00214	CcSEcCtD
Halofantrine—Decreased appetite—Betamethasone—multiple sclerosis	0.000504	0.00214	CcSEcCtD
Halofantrine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000504	0.00214	CcSEcCtD
Halofantrine—Nausea—Mitoxantrone—multiple sclerosis	0.000503	0.00214	CcSEcCtD
Halofantrine—Back pain—Methotrexate—multiple sclerosis	0.0005	0.00212	CcSEcCtD
Halofantrine—Fatigue—Dexamethasone—multiple sclerosis	0.0005	0.00212	CcSEcCtD
Halofantrine—Fatigue—Betamethasone—multiple sclerosis	0.0005	0.00212	CcSEcCtD
Halofantrine—Anorexia—Prednisone—multiple sclerosis	0.000481	0.00204	CcSEcCtD
Halofantrine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00048	0.00204	CcSEcCtD
Halofantrine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000478	0.00203	CcSEcCtD
Halofantrine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000478	0.00203	CcSEcCtD
Halofantrine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000474	0.00201	CcSEcCtD
Halofantrine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000474	0.00201	CcSEcCtD
Halofantrine—Malaise—Methotrexate—multiple sclerosis	0.000466	0.00198	CcSEcCtD
Halofantrine—Urticaria—Dexamethasone—multiple sclerosis	0.000461	0.00196	CcSEcCtD
Halofantrine—Urticaria—Betamethasone—multiple sclerosis	0.000461	0.00196	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00046	0.00195	CcSEcCtD
Halofantrine—Dizziness—Prednisolone—multiple sclerosis	0.00046	0.00195	CcSEcCtD
Halofantrine—Asthenia—Triamcinolone—multiple sclerosis	0.000459	0.00195	CcSEcCtD
Halofantrine—Abdominal pain—Betamethasone—multiple sclerosis	0.000458	0.00195	CcSEcCtD
Halofantrine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000458	0.00195	CcSEcCtD
Halofantrine—Asthenia—Methylprednisolone—multiple sclerosis	0.000458	0.00194	CcSEcCtD
Halofantrine—Paraesthesia—Prednisone—multiple sclerosis	0.000453	0.00193	CcSEcCtD
Halofantrine—Pruritus—Triamcinolone—multiple sclerosis	0.000452	0.00192	CcSEcCtD
Halofantrine—Cough—Methotrexate—multiple sclerosis	0.000451	0.00192	CcSEcCtD
Halofantrine—Pruritus—Methylprednisolone—multiple sclerosis	0.000451	0.00192	CcSEcCtD
Halofantrine—Convulsion—Methotrexate—multiple sclerosis	0.000448	0.0019	CcSEcCtD
Halofantrine—Dyspepsia—Prednisone—multiple sclerosis	0.000445	0.00189	CcSEcCtD
Halofantrine—Arthralgia—Methotrexate—multiple sclerosis	0.00044	0.00187	CcSEcCtD
Halofantrine—Chest pain—Methotrexate—multiple sclerosis	0.00044	0.00187	CcSEcCtD
Halofantrine—Myalgia—Methotrexate—multiple sclerosis	0.00044	0.00187	CcSEcCtD
Halofantrine—Decreased appetite—Prednisone—multiple sclerosis	0.000439	0.00186	CcSEcCtD
Halofantrine—Rash—Prednisolone—multiple sclerosis	0.000438	0.00186	CcSEcCtD
Halofantrine—Dermatitis—Prednisolone—multiple sclerosis	0.000438	0.00186	CcSEcCtD
Halofantrine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000436	0.00185	CcSEcCtD
Halofantrine—Fatigue—Prednisone—multiple sclerosis	0.000435	0.00185	CcSEcCtD
Halofantrine—Headache—Prednisolone—multiple sclerosis	0.000435	0.00185	CcSEcCtD
Halofantrine—Discomfort—Methotrexate—multiple sclerosis	0.000435	0.00185	CcSEcCtD
Halofantrine—Constipation—Prednisone—multiple sclerosis	0.000432	0.00183	CcSEcCtD
Halofantrine—Confusional state—Methotrexate—multiple sclerosis	0.000426	0.00181	CcSEcCtD
Halofantrine—Dizziness—Triamcinolone—multiple sclerosis	0.000423	0.00179	CcSEcCtD
Halofantrine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000422	0.00179	CcSEcCtD
Halofantrine—Dizziness—Methylprednisolone—multiple sclerosis	0.000422	0.00179	CcSEcCtD
Halofantrine—Feeling abnormal—Prednisone—multiple sclerosis	0.000416	0.00177	CcSEcCtD
Halofantrine—Asthenia—Dexamethasone—multiple sclerosis	0.000416	0.00177	CcSEcCtD
Halofantrine—Asthenia—Betamethasone—multiple sclerosis	0.000416	0.00177	CcSEcCtD
Halofantrine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000413	0.00175	CcSEcCtD
Halofantrine—Nausea—Prednisolone—multiple sclerosis	0.000413	0.00175	CcSEcCtD
Halofantrine—Pruritus—Dexamethasone—multiple sclerosis	0.00041	0.00174	CcSEcCtD
Halofantrine—Pruritus—Betamethasone—multiple sclerosis	0.00041	0.00174	CcSEcCtD
Halofantrine—Vomiting—Triamcinolone—multiple sclerosis	0.000406	0.00173	CcSEcCtD
Halofantrine—Vomiting—Methylprednisolone—multiple sclerosis	0.000405	0.00172	CcSEcCtD
Halofantrine—Rash—Triamcinolone—multiple sclerosis	0.000403	0.00171	CcSEcCtD
Halofantrine—Dermatitis—Triamcinolone—multiple sclerosis	0.000403	0.00171	CcSEcCtD
Halofantrine—Anorexia—Methotrexate—multiple sclerosis	0.000402	0.00171	CcSEcCtD
Halofantrine—Rash—Methylprednisolone—multiple sclerosis	0.000402	0.00171	CcSEcCtD
Halofantrine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000402	0.00171	CcSEcCtD
Halofantrine—Urticaria—Prednisone—multiple sclerosis	0.000401	0.0017	CcSEcCtD
Halofantrine—Headache—Triamcinolone—multiple sclerosis	0.0004	0.0017	CcSEcCtD
Halofantrine—Headache—Methylprednisolone—multiple sclerosis	0.000399	0.0017	CcSEcCtD
Halofantrine—Abdominal pain—Prednisone—multiple sclerosis	0.000399	0.0017	CcSEcCtD
Halofantrine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000397	0.00169	CcSEcCtD
Halofantrine—Diarrhoea—Betamethasone—multiple sclerosis	0.000397	0.00169	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000385	0.00163	CcSEcCtD
Halofantrine—Dizziness—Betamethasone—multiple sclerosis	0.000383	0.00163	CcSEcCtD
Halofantrine—Dizziness—Dexamethasone—multiple sclerosis	0.000383	0.00163	CcSEcCtD
Halofantrine—Nausea—Triamcinolone—multiple sclerosis	0.00038	0.00161	CcSEcCtD
Halofantrine—Paraesthesia—Methotrexate—multiple sclerosis	0.000379	0.00161	CcSEcCtD
Halofantrine—Nausea—Methylprednisolone—multiple sclerosis	0.000379	0.00161	CcSEcCtD
Halofantrine—Dyspepsia—Methotrexate—multiple sclerosis	0.000372	0.00158	CcSEcCtD
Halofantrine—Vomiting—Betamethasone—multiple sclerosis	0.000369	0.00157	CcSEcCtD
Halofantrine—Vomiting—Dexamethasone—multiple sclerosis	0.000369	0.00157	CcSEcCtD
Halofantrine—Decreased appetite—Methotrexate—multiple sclerosis	0.000367	0.00156	CcSEcCtD
Halofantrine—Rash—Dexamethasone—multiple sclerosis	0.000366	0.00155	CcSEcCtD
Halofantrine—Rash—Betamethasone—multiple sclerosis	0.000366	0.00155	CcSEcCtD
Halofantrine—Dermatitis—Betamethasone—multiple sclerosis	0.000365	0.00155	CcSEcCtD
Halofantrine—Dermatitis—Dexamethasone—multiple sclerosis	0.000365	0.00155	CcSEcCtD
Halofantrine—Fatigue—Methotrexate—multiple sclerosis	0.000364	0.00155	CcSEcCtD
Halofantrine—Headache—Betamethasone—multiple sclerosis	0.000363	0.00154	CcSEcCtD
Halofantrine—Headache—Dexamethasone—multiple sclerosis	0.000363	0.00154	CcSEcCtD
Halofantrine—Asthenia—Prednisone—multiple sclerosis	0.000362	0.00154	CcSEcCtD
Halofantrine—Pruritus—Prednisone—multiple sclerosis	0.000357	0.00152	CcSEcCtD
Halofantrine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000348	0.00148	CcSEcCtD
Halofantrine—Diarrhoea—Prednisone—multiple sclerosis	0.000346	0.00147	CcSEcCtD
Halofantrine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000345	0.00147	CcSEcCtD
Halofantrine—Nausea—Dexamethasone—multiple sclerosis	0.000344	0.00146	CcSEcCtD
Halofantrine—Nausea—Betamethasone—multiple sclerosis	0.000344	0.00146	CcSEcCtD
Halofantrine—Urticaria—Methotrexate—multiple sclerosis	0.000335	0.00142	CcSEcCtD
Halofantrine—Dizziness—Prednisone—multiple sclerosis	0.000334	0.00142	CcSEcCtD
Halofantrine—Abdominal pain—Methotrexate—multiple sclerosis	0.000334	0.00142	CcSEcCtD
Halofantrine—Vomiting—Prednisone—multiple sclerosis	0.000321	0.00136	CcSEcCtD
Halofantrine—Rash—Prednisone—multiple sclerosis	0.000318	0.00135	CcSEcCtD
Halofantrine—Dermatitis—Prednisone—multiple sclerosis	0.000318	0.00135	CcSEcCtD
Halofantrine—Headache—Prednisone—multiple sclerosis	0.000316	0.00134	CcSEcCtD
Halofantrine—Asthenia—Methotrexate—multiple sclerosis	0.000303	0.00129	CcSEcCtD
Halofantrine—Nausea—Prednisone—multiple sclerosis	0.0003	0.00127	CcSEcCtD
Halofantrine—Pruritus—Methotrexate—multiple sclerosis	0.000299	0.00127	CcSEcCtD
Halofantrine—Diarrhoea—Methotrexate—multiple sclerosis	0.000289	0.00123	CcSEcCtD
Halofantrine—Dizziness—Methotrexate—multiple sclerosis	0.000279	0.00119	CcSEcCtD
Halofantrine—Vomiting—Methotrexate—multiple sclerosis	0.000268	0.00114	CcSEcCtD
Halofantrine—Rash—Methotrexate—multiple sclerosis	0.000266	0.00113	CcSEcCtD
Halofantrine—Dermatitis—Methotrexate—multiple sclerosis	0.000266	0.00113	CcSEcCtD
Halofantrine—Headache—Methotrexate—multiple sclerosis	0.000264	0.00112	CcSEcCtD
Halofantrine—Nausea—Methotrexate—multiple sclerosis	0.000251	0.00106	CcSEcCtD
